Amgen ($AMGN) announced that the FDA has approved
Post# of 64135
Posted On: 10/28/2015 9:11:45 AM
Amgen ($AMGN) announced that the FDA has approved the BLA for IMLYGIC, a genetically modified oncolytic viral therapy used for local treatment of cutaneous, subcutaneous and nodal lesions in patients with melanoma recurrent after initial surgery.
(0)
(0)Scroll down for more posts ▼